Quick Answer
Universe Pharmaceuticals INC reported Cash and Equivalents of $8.08 million for fiscal year 2021.
Universe Pharmaceuticals INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2021 | $8.08M | -19.7% |
| 2020 | $10.06M | +216.6% |
| 2019 | $3.18M | -48.7% |
| 2018 | $6.19M | — |
- Universe Pharmaceuticals INC showed a decrease of -19.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2021 period, Universe Pharmaceuticals INC’s cash and equivalents has grown by 30.5% (from $6.19 million to $8.08 million).
- The most recent figure is from Universe Pharmaceuticals INC’s fiscal year 2021 report (Form 20-F), filed with the SEC on January 31, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: